高分子风险骨髓增殖性瘤的发病和管理
Victoria Y Ling1, Florian H Heidel2, Megan J Bywater3
1QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia; Department of Haematology, Princess Alexandra Hospital, Brisbane, Queensland, Australia; Pathology Queensland, Brisbane, Queensland, Australia; The University of Queensland, Brisbane, QLD.
Haematologica
|December 5, 2024
概括
骨髓增殖性瘤 (MPN) 涉及影响JAK信号的驱动突变. 额外的突变会影响疾病的进展,影响风险分层和临床管理,以获得更好的结果.
科学领域:
- 血液学 血液学 血液学
- 在瘤学瘤学.
- 分子生物学分子生物学
背景情况:
- 经典骨髓增殖性瘤 (MPN) 是克隆干细胞疾病.
- 构成性JAK信号通路的激活是MPN的标志性特征,由特定突变驱动.
- 除了MPN驱动突变外,同时发生的体内突变也很常见,影响疾病行为.
研究的目的:
- 审查目前关于MPN克隆进化的假设.
- 阐明伴随突变驱动疾病进展的功能机制.
- 讨论高分子风险MPN的定义和临床影响.
主要方法:
- 关于MPN克隆进化的当前研究的文献综述.
- 对MPN同时发生的体位突变的功能机制的分析.
- 讨论遗传风险分层及其对临床管理的影响.
主要成果:
- 同时发生的突变对MPN的呈现和进展有显著的贡献.
- 了解这些额外的突变对于定义高分子风险MPN至关重要.
- 遗传风险分层提供了一条改善MPN患者临床结果的途径.
结论:
- 在MPN中,克隆进化涉及驱动器和并发突变的复杂相互作用.
- 同时突变是MPN风险和进展的关键决定因素.
- 将遗传洞察纳入临床实践可以优化MPN管理和患者的治疗结果.
相关概念视频
Differentiation of Common Myeloid Progenitor Cells
3.2K
Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
3.2K
Abnormal Proliferation
4.4K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.4K
Bone Marrow Sampling and Transplants
284
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
284
Lineage Commitment
3.0K
Commitment is the process whereby stem cells:
3.0K
Tumor Progression
6.2K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.2K
Regulation of Hematopoietic Stem Cells
3.1K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.1K


